Gritstone, BioXcel Expect to Report Catalysts in July 2020; 2Q SanaCurrents Update
Gritstone Oncology (NASDAQ:GRTS) plans to hold a conference call and [...]
Gritstone Oncology (NASDAQ:GRTS) plans to hold a conference call and [...]
Harpoon Therapeutics (NASDAQ:HARP), a biotechnology company developing an antibody platform [...]
Harpoon Therapeutics (NASDAQ:HARP) said last week it would present interim [...]
Onconova Coverage suspended, Oragenics falls short in Phase II trial. [...]
$HARP Probability Sentiment SUMMARY SanaCurrents [...]